Tipifarnib Versus Best Supportive Care in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)

This study has been completed.

Study NCT00093990 Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

First Received: October 7, 2004 Last Updated: September 19, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	October 2007
Estimated Primary Completion Date:	No date given